CZ188299A3 - Transfekční přípravek vhodný pro genovou terapii, který obsahuje rekombinantní virus a transfekční činidlo - Google Patents

Transfekční přípravek vhodný pro genovou terapii, který obsahuje rekombinantní virus a transfekční činidlo Download PDF

Info

Publication number
CZ188299A3
CZ188299A3 CZ991882A CZ188299A CZ188299A3 CZ 188299 A3 CZ188299 A3 CZ 188299A3 CZ 991882 A CZ991882 A CZ 991882A CZ 188299 A CZ188299 A CZ 188299A CZ 188299 A3 CZ188299 A3 CZ 188299A3
Authority
CZ
Czechia
Prior art keywords
composition according
group
composition
cell
independently
Prior art date
Application number
CZ991882A
Other languages
Czech (cs)
English (en)
Inventor
Nathalie Aubailly
Patrick Benoit
Didier Branellec
Roux Aude Le
Abderrahim Mahfoudi
Nathalie Ratet
Original Assignee
Rhone-Poulenc Rorer S. A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone-Poulenc Rorer S. A. filed Critical Rhone-Poulenc Rorer S. A.
Publication of CZ188299A3 publication Critical patent/CZ188299A3/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2810/00—Vectors comprising a targeting moiety
    • C12N2810/10—Vectors comprising a non-peptidic targeting moiety
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2810/00—Vectors comprising a targeting moiety
    • C12N2810/40—Vectors comprising a peptide as targeting moiety, e.g. a synthetic peptide, from undefined source
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2810/00—Vectors comprising a targeting moiety
    • C12N2810/50—Vectors comprising as targeting moiety peptide derived from defined protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2810/00—Vectors comprising a targeting moiety
    • C12N2810/50—Vectors comprising as targeting moiety peptide derived from defined protein
    • C12N2810/80—Vectors comprising as targeting moiety peptide derived from defined protein from vertebrates
    • C12N2810/85—Vectors comprising as targeting moiety peptide derived from defined protein from vertebrates mammalian
    • C12N2810/859—Vectors comprising as targeting moiety peptide derived from defined protein from vertebrates mammalian from immunoglobulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Plant Pathology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CZ991882A 1996-11-29 1997-11-28 Transfekční přípravek vhodný pro genovou terapii, který obsahuje rekombinantní virus a transfekční činidlo CZ188299A3 (cs)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9614693A FR2756491B1 (fr) 1996-11-29 1996-11-29 Composition transfectante utile en therapie genique associan t a un virus recombinant incorporant un acide nucleique exog ene, un agent de transfection non viral et non plasmidique

Publications (1)

Publication Number Publication Date
CZ188299A3 true CZ188299A3 (cs) 1999-09-15

Family

ID=9498192

Family Applications (1)

Application Number Title Priority Date Filing Date
CZ991882A CZ188299A3 (cs) 1996-11-29 1997-11-28 Transfekční přípravek vhodný pro genovou terapii, který obsahuje rekombinantní virus a transfekční činidlo

Country Status (13)

Country Link
EP (1) EP0948636A1 (sk)
JP (1) JP2001514485A (sk)
KR (1) KR20000057307A (sk)
AU (1) AU737846B2 (sk)
BR (1) BR9713434A (sk)
CA (1) CA2272637A1 (sk)
CZ (1) CZ188299A3 (sk)
FR (1) FR2756491B1 (sk)
HU (1) HUP9904201A3 (sk)
IL (1) IL130053A0 (sk)
NO (1) NO992577L (sk)
SK (1) SK70999A3 (sk)
WO (1) WO1998023765A1 (sk)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100764890B1 (ko) * 2005-11-14 2007-10-09 한국화학연구원 폴리에틸렌이민과 인지질을 접합하여 제조된 리포솜을이용한 항암주사제 및 이의 제조방법
WO2008097623A2 (en) * 2007-02-07 2008-08-14 Gradalis, Inc. Methods and compositions for modulating sialic acid production and treating hereditary inclusion body myopathy
KR100980395B1 (ko) 2008-06-27 2010-09-07 재단법인서울대학교산학협력재단 비-바이러스성 유전자 전달체용 중합체/유전자 복합체
JP5944622B2 (ja) * 2011-04-08 2016-07-05 株式会社ブリヂストン 遺伝子導入剤組成物
CN104169422B (zh) 2012-03-02 2017-04-26 国立研究开发法人科学技术振兴机构 功能性核酸分子的构建方法和该方法中使用的核酸组合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2646161B1 (fr) * 1989-04-17 1991-07-05 Centre Nat Rech Scient Nouvelles lipopolyamines, leur preparation et leur emploi
US5552309A (en) * 1994-09-30 1996-09-03 Indiana University Foundation Use of polyols for improving the introduction of genetic material into cells
FR2727679B1 (fr) * 1994-12-05 1997-01-03 Rhone Poulenc Rorer Sa Nouveaux agents de transfection et leurs applications pharmaceutiques
FR2730637B1 (fr) * 1995-02-17 1997-03-28 Rhone Poulenc Rorer Sa Composition pharmaceutique contenant des acides nucleiques, et ses utilisations
FR2741066B1 (fr) * 1995-11-14 1997-12-12 Rhone Poulenc Rorer Sa Nouveaux agents de transfection et leurs applications pharmaceutiques

Also Published As

Publication number Publication date
HUP9904201A1 (hu) 2000-04-28
SK70999A3 (en) 2000-03-13
AU7401098A (en) 1998-06-22
WO1998023765A1 (fr) 1998-06-04
BR9713434A (pt) 2000-02-01
IL130053A0 (en) 2000-02-29
JP2001514485A (ja) 2001-09-11
FR2756491A1 (fr) 1998-06-05
FR2756491B1 (fr) 1999-01-08
AU737846B2 (en) 2001-08-30
KR20000057307A (ko) 2000-09-15
NO992577L (no) 1999-07-28
CA2272637A1 (fr) 1998-06-04
HUP9904201A3 (en) 2002-01-28
EP0948636A1 (fr) 1999-10-13
NO992577D0 (no) 1999-05-28

Similar Documents

Publication Publication Date Title
US6020202A (en) Composition and methods for transfecting eukaryotic cells
JP4380796B2 (ja) 核酸を含む組成物、調製および使用
US5928944A (en) Method of adenoviral-medicated cell transfection
US5631237A (en) Method for producing in vivo delivery of therapeutic agents via liposomes
ES2278556T3 (es) Virus adeno asociado recombinante.
JP4275728B2 (ja) 核酸を含有する組成物、その製造および使用
US20100179212A1 (en) Pharmaceutical composition which improves in vivo gene transfer
SK111897A3 (en) Pharmaceutical composition suitable for nucleic acid transfection and use such composition for transferring nucleic acid
JP2000509404A (ja) 遺伝物質の導入システムとしてのカチオン性ヴィロソーム
US5962429A (en) Complexes of adenovirus with cationic molecules
AU720697B2 (en) Pharmaceutical composition which is useful for the transfection of nucleic acids, and uses thereof
US7919310B2 (en) Constitutive gene expression in conjunction with ionizing radiation
CZ295225B6 (cs) Amidiniový derivát a farmaceutický prostředek tento derivát obsahující
CZ188299A3 (cs) Transfekční přípravek vhodný pro genovou terapii, který obsahuje rekombinantní virus a transfekční činidlo
SK282685B6 (sk) Kompozícia tvorená stabilizovanými časticami obsahujúcimi transfekčné činidlo alebo činidlá a nukleovú kyselinu a spôsob jej prípravy
JP2002523054A (ja) ポリマーにより修飾されたアデノウイルスのカチオン性複合体
Mizuno et al. Improvement of transduction efficiency of recombinant adeno‐associated virus vector by entrapment in multilamellar liposomes
EP1363676B1 (en) Method of enhancing delivery of a therapeutic nucleic acid
AU2002237910A1 (en) Method of enhancing delivery of a therapeutic nucleic acid
Conese et al. NONVIRAL AND VIRAL VECTORS FOR GENE THERAPY OF CYSTIC FIBROSIS LUNG DISEASE
MXPA97006016A (en) Composition containing nucleic acids, preparation and use
CZ20002713A3 (cs) Činidlo pro přenos nukleové kyseliny citlivé k redukujícím podmínkám, farmaceutické » přípravky obsahující toto činidlo a použití činidla

Legal Events

Date Code Title Description
PD00 Pending as of 2000-06-30 in czech republic